Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Wynter, E. A.
Right arrow Articles by Testa, N.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Wynter, E. A.
Right arrow Articles by Testa, N.G.
Stem Cells, Vol. 16, No. 6, 387-396, November 1998
© 1998 AlphaMed Press

CD34+AC133+ Cells Isolated from Cord Blood are Highly Enriched in Long-Term Culture-Initiating Cells, NOD/SCID-Repopulating Cells and Dendritic Cell Progenitors

E. A. de Wyntera, D. Buckd, C. Harta, R. Heywooda, L.H. Coutinhoa, A. Claytonc, J.A. Raffertya, D. Burtc, G. Guenecheab, J. A. Buerenb, D. Gagena, L. J. Fairbairna, B.I. Lorda, N.G. Testaa

a CRC Section of Haemopoietic Cell and Gene Therapeutics, Paterson Institute for Cancer Research, Withington, Manchester, United Kingdom;
b CIEMAT, Department of Molecular and Cellular Biology, Avenida Complutense, Madrid, Spain;
c CRC Section of Tumour and Cell Biology, Paterson Institute;
d AmCell Corp., Sunnyvale, CA, USA

Key Words. CD34+ cells • AC133+ • LTC-IC • NOD/SCID mice • Dendritic cells

Dr. E.A. de Wynter, CRC Section of Haemopoietic Cell and Gene Therapeutics, Paterson Institute for Cancer Research, Wilmslow Road, Manchester M20 4BX, United Kingdom.

The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood.

Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133 cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture. Only the CD34+AC133+ cells were capable of repopulating NOD/SCID mice. Human cells were detectable as early as day 20, with increased levels (67%) apparent 40 days post-transplantation. Five thousand CD34+AC133+ cells engrafted about 20% of the mice, while no engraftment was observed in animals transplanted with up to 1.2 x 105 CD34+AC133 cells. The CD34+AC133+ population was also enriched (sevenfold) in dendritic cell precursors, and the dendritic cells generated were functionally active in a mixed lymphocyte reaction assay. AC133+ cells should be useful in the study of cellular and molecular mechanisms regulating primitive hemopoietic cells.




This article has been cited by other articles:


Home page
Int J EpidemiolHome page
M. Amoli, D Carthy, H Platt, and W. Ollier
EBV Immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood
Int. J. Epidemiol., April 1, 2008; 37(suppl_1): i41 - i45.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
K. Yamamura, K. Ohishi, M. Masuya, E. Miyata, Y. Sugimoto, S. Nakamura, A. Fujieda, H. Araki, and N. Katayama
Ex Vivo Culture of Human Cord Blood Hematopoietic Stem/Progenitor Cells Adversely Influences Their Distribution to Other Bone Marrow Compartments After Intra-Bone Marrow Transplantation
Stem Cells, February 1, 2008; 26(2): 543 - 549.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Shao, C. C. White, M. J. Dabrowski, T. J. Kavanagh, M. L. Eckert, and E. P. Gallagher
The Role of Mitochondrial and Oxidative Injury in BDE 47 Toxicity to Human Fetal Liver Hematopoietic Stem Cells
Toxicol. Sci., January 1, 2008; 101(1): 81 - 90.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
O. Christ, K. Lucke, S. Imren, K. Leung, M. Hamilton, A. Eaves, C. Smith, and C. Eaves
Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity
Haematologica, September 1, 2007; 92(9): 1165 - 1172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. Balasubramaniam, C. F. Mervis, A. M. Maxey, N. E. Markham, and S. H. Abman
Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia
Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1073 - L1084.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X. L. Aranguren, A. Luttun, C. Clavel, C. Moreno, G. Abizanda, M. A. Barajas, B. Pelacho, M. Uriz, M. Arana, A. Echavarri, et al.
In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells
Blood, March 15, 2007; 109(6): 2634 - 2642.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. Shao, P. L. Stapleton, Y. S. Lin, and E. P. Gallagher
Cytochrome P450 and Glutathione S-Transferase mRNA Expression in Human Fetal Liver Hematopoietic Stem Cells
Drug Metab. Dispos., January 1, 2007; 35(1): 168 - 175.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
G Perrella, P Brusini, R Spelat, P Hossain, A Hopkinson, and H S Dua
Expression of haematopoietic stem cell markers, CD133 and CD34 on human corneal keratocytes
Br. J. Ophthalmol., January 1, 2007; 91(1): 94 - 99.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. Suzuki, Y. Yokoyama, K. Kumano, M. Takanashi, S. Kozuma, T. Takato, T. Nakahata, M. Nishikawa, S. Sakano, M. Kurokawa, et al.
Highly Efficient Ex Vivo Expansion of Human Hematopoietic Stem Cells Using Delta1-Fc Chimeric Protein
Stem Cells, November 1, 2006; 24(11): 2456 - 2465.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. J. Stuckey, C. A. Carr, E. Martin-Rendon, D. J. Tyler, C. Willmott, P. J. Cassidy, S. J.M. Hale, J. E. Schneider, L. Tatton, S. E. Harding, et al.
Iron Particles for Noninvasive Monitoring of Bone Marrow Stromal Cell Engraftment into, and Isolation of Viable Engrafted Donor Cells from, the Heart
Stem Cells, August 1, 2006; 24(8): 1968 - 1975.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Ma, Y. Ladilov, J. M. Moebius, L. Ong, C. Piechaczek, A. David, A. Kaminski, Y.-H. Choi, W. Li, D. Egger, et al.
Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells
Cardiovasc Res, July 1, 2006; 71(1): 158 - 169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. R. Thom, V. M. Bhopale, O. C. Velazquez, L. J. Goldstein, L. H. Thom, and D. G. Buerk
Stem cell mobilization by hyperbaric oxygen
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1378 - H1386.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. Jaatinen, H. Hemmoranta, S. Hautaniemi, J. Niemi, D. Nicorici, J. Laine, O. Yli-Harja, and J. Partanen
Global Gene Expression Profile of Human Cord Blood-Derived CD133+ Cells
Stem Cells, March 1, 2006; 24(3): 631 - 641.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. A. Hess, L. Wirthlin, T. P. Craft, P. E. Herrbrich, S. A. Hohm, R. Lahey, W. C. Eades, M. H. Creer, and J. A. Nolta
Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells
Blood, March 1, 2006; 107(5): 2162 - 2169.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. Bornstein, A. I. Flores, M. A. Montalban, M. J. del Rey, J. de la Serna, and F. Gilsanz
A Modified Cord Blood Collection Method Achieves Sufficient Cell Levels for Transplantation in Most Adult Patients
Stem Cells, March 1, 2005; 23(3): 324 - 334.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. A. Vodyanik, J. A. Bork, J. A. Thomson, and I. I. Slukvin
Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential
Blood, January 15, 2005; 105(2): 617 - 626.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
W. Tao, M. Wang, E. D. Voss, R. R. Cocklin, J. A. Smith, S. H. Cooper, and H. E. Broxmeyer
Comparative Proteomic Analysis of Human CD34+ Stem/Progenitor Cells and Mature CD15+ Myeloid Cells
Stem Cells, November 1, 2004; 22(6): 1003 - 1014.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
Y. J. Summers, C. M. Heyworth, E. A. de Wynter, C. A. Hart, J. Chang, and N. G. Testa
AC133+ G0 Cells from Cord Blood Show a High Incidence of Long-Term Culture-Initiating Cells and a Capacity for More Than 100 Million-Fold Amplification of Colony-Forming Cells In Vitro
Stem Cells, September 1, 2004; 22(5): 704 - 715.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
O. Umland, H. Heine, M. Miehe, K. Marienfeld, K. H. Staubach, and A. J. Ulmer
Induction of various immune modulatory molecules in CD34+ hematopoietic cells
J. Leukoc. Biol., April 1, 2004; 75(4): 671 - 679.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. M. Bohmer
IL-3-Dependent Early Erythropoiesis Is Stimulated by Autocrine Transforming Growth Factor Beta
Stem Cells, March 1, 2004; 22(2): 216 - 224.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
P. Denning-Kendall, S. Singha, B. Bradley, and J. Hows
Cobblestone Area-Forming Cells in Human Cord Blood Are Heterogeneous and Differ from Long-Term Culture-Initiating Cells
Stem Cells, November 1, 2003; 21(6): 694 - 701.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. N. Schwartz, B. A. Vance, B. M. Levine, M. Fukazawa, W. G. Telford, D. Cesar, M. Hellerstein, and R. E. Gress
Proliferation kinetics of subpopulations of human marrow cells determined by quantifying in vivo incorporation of [2H2]-glucose into DNA of S-phase cells
Blood, September 15, 2003; 102(6): 2068 - 2073.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C. P. McGuckin, N. Forraz, M.-O. Baradez, C. Lojo-Rial, D. Wertheim, K. Whiting, S. M. Watt, and R. Pettengell
Colocalization Analysis of Sialomucins CD34 and CD164
Stem Cells, March 1, 2003; 21(2): 162 - 170.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. L. Abbott, A.-M. Colapietro, Y. Barnes, F. Marini, M. Andreeff, and B. P. Sorrentino
Low levels of ABCG2 expression in adult AML blast samples
Blood, December 15, 2002; 100(13): 4594 - 4601.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. E. Burger, S. Coetzee, W. L. McKeehan, M. Kan, P. Cook, Y. Fan, T. Suda, R. P. Hebbel, N. Novitzky, W. A. Muller, et al.
Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells
Blood, November 15, 2002; 100(10): 3527 - 3535.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. E. Stringer, M. J. Forster, B. Mulloy, C. R. Bishop, G. J. Graham, and J. T. Gallagher
Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha
Blood, August 13, 2002; 100(5): 1543 - 1550.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. M. Gehling, S. Ergun, U. Schumacher, C. Wagener, K. Pantel, M. Otte, G. Schuch, P. Schafhausen, T. Mende, N. Kilic, et al.
In vitro differentiation of endothelial cells from AC133-positive progenitor cells
Blood, May 15, 2000; 95(10): 3106 - 3112.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
K. Matsumoto, K. Yasui, N. Yamashita, Y. Horie, T. Yamada, Y. Tani, H. Shibata, and T. Nakano
In Vitro Proliferation Potential of AC133 Positive Cells in Peripheral Blood
Stem Cells, May 1, 2000; 18(3): 196 - 203.
[Abstract] [Full Text]


Home page
BloodHome page
L. Gallacher, B. Murdoch, D. M. Wu, F. N. Karanu, M. Keeney, and M. Bhatia
Isolation and characterization of human CD34-Lin- and CD34+Lin- hematopoietic stem cells using cell surface markers AC133 and CD7
Blood, May 1, 2000; 95(9): 2813 - 2820.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Corbeil, K. Roper, A. Hellwig, M. Tavian, S. Miraglia, S. M. Watt, P. J. Simmons, B. Peault, D. W. Buck, and W. B. Huttner
The Human AC133 Hematopoietic Stem Cell Antigen Is also Expressed in Epithelial Cells and Targeted to Plasma Membrane Protrusions
J. Biol. Chem., February 25, 2000; 275(8): 5512 - 5520.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 1998 by AlphaMed Press.